Advanced search
Publication Cover
Vascular Health and Risk Management Volume 17, 2021 - Issue
Submit an article Journal homepage
263
Views
8
CrossRef citations to date
0
Altmetric
Review

Elevated Lipoprotein(a): Background, Current Insights and Future Potential Therapies

Ahmed Handhle1 Department of Metabolic Medicine/Chemical Pathology, Addenbrookes Hospital, Cambridge, UK
,
Adie Viljoen2 Department of Metabolic Medicine/Chemical Pathology, North & East Hertfordshire Hospitals Trust, Lister Hospital, Hertfordshire, UKORCID Iconhttps://orcid.org/0000-0002-3125-7998
ORCID Icon &
Anthony S Wierzbicki3 Department of Metabolic Medicine/Chemical Pathology, Guy’s & St Thomas’, Hospitals, London, SE1 7EH, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2756-372X
ORCID Icon
Pages 527-542 | Published online: 07 Sep 2021

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Axelle Deconinck, Sofia Morra, Nina Glassée & Philippe van de Borne. (2023) Value of repeated measurements of lipoprotein (a) to assess cardiovascular risk: a retrospective study. Acta Cardiologica 78:5, pages 536-542.
Read now
Leon A. Simons & Judith Simons. (2023) Lipoprotein(a) and the risk of recurrent coronary heart disease: the Dubbo Study. Current Medical Research and Opinion 39:7, pages 933-938.
Read now

Articles from other publishers (6)

Julie Caroline Sæther, Elisabeth Kleivhaug Vesterbekkmo, Bruna Gigante, Guro Fanneløb Giskeødegård, Tone Frost Bathen, Turid Follestad, Rune Wiseth, Erik Madssen & Anja Bye. (2023) The association between circulating lipoprotein subfractions and lipid content in coronary atheromatous plaques assessed by near-infrared spectroscopy. IJC Heart & Vasculature 46, pages 101215.
Crossref
Ralf Martz Sulague, Nina Nicole M. Suan, Michael F. Mendoza & Carl J. Lavie. (2022) The associations between exercise and lipid biomarkers. Progress in Cardiovascular Diseases 75, pages 59-68.
Crossref
Adam J. Nelson, Allan D. Sniderman, Marc Ditmarsch, Mary R. Dicklin, Stephen J. Nicholls, Michael H. Davidson & John J. P. Kastelein. (2022) Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels. International Journal of Molecular Sciences 23:16, pages 9417.
Crossref
Mary Katherine Cheeley, Joseph J. Saseen, Anandita Agarwala, Sudha Ravilla, Nicole Ciffone, Terry A. Jacobson, Dave L. Dixon & Kevin C. Maki. (2022) NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient. Journal of Clinical Lipidology 16:4, pages 361-375.
Crossref
Pyotr Telyuk, David Austin, Ahai Luvai & Azfar Zaman. (2022) Lipoprotein(a): Insights for the Practicing Clinician. Journal of Clinical Medicine 11:13, pages 3673.
Crossref
Klaus G. Parhofer. (2022) New targets for treating hypertriglyceridemia. Current Opinion in Endocrinology, Diabetes & Obesity 29:2, pages 106-111.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.